Investing
Merck in late-stage talks to acquire Prometheus Biosciences -WSJ
© Reuters. FILE PHOTO: Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly
(Reuters) – Merck & Co is in late-stage talks to acquire Prometheus Biosciences Inc to get its hands on promising immune disease treatments, the Wall Street Journal reported on Sunday citing people familiar with the matter.
Read the full article here
-
Investing4 days ago
This All-Access Pass to Learning Is Now $20 for Black Friday
-
Investing7 days ago
Are You Missing These Hidden Warning Signs When Hiring?
-
Passive Income4 days ago
How to Create a Routine That Balances Rest and Business Success
-
Make Money7 days ago
7 Common Things You Should Never Buy New
-
Side Hustles5 days ago
Apple Prepares a New AI-Powered Siri to Compete With ChatGPT
-
Side Hustles6 days ago
MIT Gives Free Tuition For Families Earning $200,000 or Less
-
Passive Income5 days ago
Customers Want More Than Just a Product — Here’s How to Keep Up
-
Investing7 days ago
Google faces call from DuckDuckGo for new EU probes into tech rule compliance By Reuters